HIV prevalence and risk behaviour in needle exchange attenders: A national study

Medical Journal of Australia

Volumn 166, Issue 5, 1997, Pages 237-240

  MacDonald, Margaret ^a   Wodak, Alex D ^b   Ali, Robert ^c   Crofts, Nick ^d   Cunningham, Phillip H ^b   Dolan, Kate A ^e   Kelaher, Margaret ^e   Loxley, Wendy M ^f   Van Beek, Ingrid ^g   Kaldor, John M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c Drug & Alcohol Services South Australia   (Australia)

^d MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f CURTIN UNIVERSITY   (Australia)

^g Curtin University of Technology ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; AUSTRALIA; FEMALE; HEALTH BEHAVIOR; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; SEXUAL BEHAVIOR; SYRINGE;

EID: 17544394736     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1997.tb140102.x     Document Type: Article

References (14)

1. Kaldor J, Elford J, Wodak A, et al. HIV prevalence among IDUs in Australia: a methodological review. Drug Alcohol Rev 1993; 12: 175-184.
2. Crofts N, Hopper JL, Milner R, et al. Blood borne virus infections among Australian injecting drug users: implications for spread of HIV. Eur J Epidemiol 1994; 10: 1-8.
3. Freedman SR, Des Jarlais DC. HIV among drug injectors: the epidemic and the response. AIDS Care 1991; 3: 239-250.
4. Stimson GV. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection. Bulletin on Narcotics 1994; 3-17.
5. Commonwealth Department of Human Services and Health. Valuing the past, investing in the future. Evaluation of the National HIV/AIDS Strategy 1993-94 to 1995-96. Looking Glass Press, 1995: 88.
6. Ross MW, Wodak A, Loxley W, et al. Staying negative: summary of the results of the Australian National AIDS and Injecting Drug Use Study, 1989-1992. Sydney: ANAIDUS, 1993.
7. Darke S, Swift W, Hall W, Ross M. Predictors of injecting and injecting risk-taking behaviour among methadone maintenance clients. Addiction 1994; 89: 311-316.
8. The National Committees for Clinical Laboratory Standards (NCCLS). Blood collection of filter-paper for neonatal screening programs. Centers for Disease Control, the Massachusetts Departments of Public Health, the New York State Department of Public Health and the National Institutes of Health. Atlanta (Ga): Centers for Disease Control, 1988.
9. Epi Info [computer program], version 5. Atlanta, Ga: Centers for Disease Control, 1991.
10. EGRET PECAN [computer program], version 0.26.6. Washington: Statistics and Epidemiology Research Corporation, 1991.
11. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986; 105: 429-435.
12. Loxley W, Curruthers S, Bevan J. In the same vein. First report of the Australian Study of HIV and Injecting Drug Use (ASHIDU). Perth: National Centre for Research into the Prevention of Drug Abuse, August 1995.
13. Crofts N, Marcus L, Meade J, et al. Determinants of HIV risk among men who have homosexual sex and inject drugs. AIDS Care 1994; 7: 647-655.
14. National Centre in HIV Epidemiology and Clinical Research. Aust HIV Surveillance Report 1995; 3: 22.